Cargando…

Dose Optimization and Targeting Strategies of Anti-Infective Agents

Detalles Bibliográficos
Autores principales:	Šíma, Martin, Slanař, Ondřej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383694/ https://www.ncbi.nlm.nih.gov/pubmed/37514056 http://dx.doi.org/10.3390/pharmaceutics15071870

Ejemplares similares

What Is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?
por: Šíma, Martin, et al.
Publicado: (2021)

Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model
por: Dvořáčková, Eliška, et al.
Publicado: (2023)

Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections
por: Murínová, Irena, et al.
Publicado: (2022)

Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients
por: Dvořáčková, Eliška, et al.
Publicado: (2022)

Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation
por: Šantavý, Petr, et al.
Publicado: (2022)

Molecular Target and Action Mechanism of Anti-Cancer Agents
por: Lee, Seok-Geun
Publicado: (2023)

Novel Anti-Cancer Agents and Cellular Targets and Their Mechanism(s) of Action
por: Allison, Simon J.
Publicado: (2022)

Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
por: Hofmann, Jiří, et al.
Publicado: (2023)

Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives
por: Hartinger, Jan Miroslav, et al.
Publicado: (2022)

Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin
por: Šíma, Martin, et al.
Publicado: (2022)

Pharmacokinetic Variability in Pre-Clinical Studies: Sample Study with Abiraterone in Rats and Implications for Short-Term Comparative Pharmacokinetic Study Designs
por: Královičová, Jana, et al.
Publicado: (2022)

Identification of Molecular Targets and Anti-Cancer Agents in GBM: New Perspectives for Cancer Therapy
por: D’Amico, Agata Grazia, et al.
Publicado: (2023)

Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy
por: Chevalier, Xavier, et al.
Publicado: (2011)

AEG-1 targeting for inhibiting inflammation: potential anti-HCC strategy
por: Reghupaty, Saranya Chidambaranathan, et al.
Publicado: (2019)

No Time Dependence of Ciprofloxacin Pharmacokinetics in Critically Ill Adults: Comparison of Individual and Population Analyses
por: Šíma, Martin, et al.
Publicado: (2021)

Special Issue “Novel Anti-Proliferative Agents”
por: Onnis, Valentina
Publicado: (2023)

Choosing an Optimal Antipsychotic Dose for Relapse Prevention
por: Davis, John M, et al.
Publicado: (2022)

Pseudo-AKI associated with targeted anti-cancer agents—the truth is in the eye of the filtration marker
por: Vanhoutte, Thomas, et al.
Publicado: (2023)

Anti-icing strategies are on the way
por: He, Zhiyuan, et al.
Publicado: (2022)

Optimization of anti-infective dosing regimens during online haemodiafiltration
por: Jager, Nynke G. L., et al.
Publicado: (2017)

Optimal Use of Biomarkers in Oncology
por: Karlikova, Marie, et al.
Publicado: (2015)

Novel Approaches to Optimize Treatment Strategies in Glaucoma
por: Kolko, Miriam, et al.
Publicado: (2021)

Hydroxy Acids, the Most Widely Used Anti-aging Agents
por: Moghimipour, Eskandar
Publicado: (2012)

Pharmacogenetics of Chronic Pain and Its Treatment
por: Světlík, Svatopluk, et al.
Publicado: (2013)

The Urgent Need for Novel Antimicrobial Agents and Strategies to Fight Antibiotic Resistance
por: D’Andrea, Marco Maria, et al.
Publicado: (2019)

Toward an optimal contraception dosing strategy
por: Gavina, Brenda Lyn A., et al.
Publicado: (2023)

Considerations on the Calculation of the Human Equivalent Dose from Toxicology Studies for Biologic Anticancer Agents
por: Elmeliegy, Mohamed, et al.
Publicado: (2021)

Targeted Therapies for Melanoma
por: Smetana, Karel, et al.
Publicado: (2020)

Strategies for HCC target discovery
por: Molina-Sánchez, Pedro, et al.
Publicado: (2017)

The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant
por: Kodetova, Martina, et al.
Publicado: (2022)

Anti-infective Agents
por: Padberg, Stephanie
Publicado: (2015)

Impact of High-Dose Anti-Infective Agents on the Osteogenic Response of Mesenchymal Stem Cells
por: Hofmann, Jakob, et al.
Publicado: (2021)

Anti-Vascular Endothelial Growth Factor Agents for Ocular Angiogenesis and Vascular Permeability
por: Kubota, Toshiaki, et al.
Publicado: (2012)

Potential of Terpenoids and Flavonoids from Asteraceae as Anti-Inflammatory, Antitumor, and Antiparasitic Agents
por: Sülsen, Valeria P., et al.
Publicado: (2017)

Anti-amyloid agents for treating incipient Alzheimer’s disease: a new hope?
por: Loureiro, Julia C., et al.
Publicado: (2022)

Antioxidants in Age-Related Diseases and Anti-Aging Strategies
por: Rusu, Marius Emil, et al.
Publicado: (2022)

Nanoparticles for Targeted Delivery of Active Agents against Tumor Cells
por: Dinarvand, Rassoul, et al.
Publicado: (2012)

Molecular targeted agents—where we are and where we are going
por: Yan, Li
Publicado: (2013)

Cardiotoxicity due to targeted anticancer agents: a growing challenge
por: Shah, Chintan P., et al.
Publicado: (2019)

Minimal Access or Optimal Access: What to Target?
por: Ansari, Ahmed
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pln7r51l62iv9lckdbhhb9l9c2